Ascentage Pharma Group International (6855.HK)

HKD 39.0

(1.3%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 2.5 Billion 2.83 Billion 2.94 Billion 1.73 Billion 1.2 Billion 1.22 Billion
Total Current Assets 1.34 Billion 1.63 Billion 1.88 Billion 1.07 Billion 909.1 Million 990.21 Million
Cash And Short Term Investments 1.06 Billion 1.5 Billion 1.74 Billion 1.02 Billion 885.05 Million 971.48 Million
Cash and Cash Equivalents 1.06 Billion 1.49 Billion 1.74 Billion 1.02 Billion 882.45 Million 957.08 Million
Short Term Investments 6.55 Million 11.9 Million 4.14 Million 3.02 Million 2.59 Million 14.39 Million
Net Receivables 145.89 Million 54.35 Million 53.96 Million - - -
Inventory 16.16 Million 9.44 Million 3.93 Million - - -
Other Current Assets 81.72 Million 68.53 Million 79.41 Million 51.61 Million 24.04 Million 6.42 Million
Total Non-Current Assets 1.15 Billion 776.25 Million 957.31 Million 599.87 Million 271.36 Million 239.15 Million
Net PPE 957.23 Million 648.72 Million 844.36 Million 477 Million 142.28 Million 33.99 Million
Good Will And Intangible Assets 110.14 Million 108.99 Million 85.1 Million 91.09 Million 96.88 Million 133.22 Million
Good Will 24.69 Million 24.69 Million 24.69 Million 24.69 Million 24.69 Million 24.69 Million
Intangible Assets 85.44 Million 84.3 Million 60.41 Million 66.4 Million 72.19 Million 108.52 Million
Long-Term Investments 18.94 Million 18.53 Million 27.84 Million 31.77 Million 32.19 Million 45.11 Million
Tax Assets 59.84 Million 54.29 Million 51.64 Million - - -
Other Non Current Assets 10.05 Million -54.29 Million -51.64 Million -599.87 Million -271.36 Million 26.82 Million
Other Assets - 417.52 Million 97.46 Million 52.12 Million 24.58 Million -
Total Liabilities 2.42 Billion 2.42 Billion 1.7 Billion 884.41 Million 314.57 Million 2.24 Billion
Total Current Liabilities 934.17 Million 881.15 Million 361.1 Million 276.14 Million 202.06 Million 105.26 Million
Account Payables 72.44 Million 95.55 Million 70.86 Million 23.36 Million 13.08 Million 5.08 Million
Tax Payables 8.38 Million 7.17 Million 3.27 Million 5.98 Million 1.6 Million 1 Million
Short Term Debt 616.4 Million 518.38 Million 49.45 Million 50.56 Million 92.19 Million 37.58 Million
Deferred Revenue - -518.38 Million -49.45 Million -50.56 Million -92.19 Million -
Other Current Liabilities 245.32 Million 785.59 Million 290.24 Million 252.78 Million 188.97 Million 62.6 Million
Total Non Current Liabilities 1.49 Billion 1.26 Billion 1.02 Billion 473.05 Million 112.51 Million 2.13 Billion
Long-Term Debt 1.17 Billion 1.26 Billion 1.02 Billion 473.05 Million 9.21 Million 4.45 Million
Deferred Revenue Non Current 287.54 Million 218.62 Million 243.27 Million 40.2 Million 35.09 Million 27.03 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 18.29 Million -230.77 Million -257.03 Million -55.56 Million 51.24 Million 2.08 Billion
Other Liabilities - 275.25 Million 317.62 Million 135.21 Million - -
Total Equity 70.63 Million 408.65 Million 1.23 Billion 846.62 Million 890.47 Million -1.01 Billion
Stock Holders Equity 60.41 Million 408.65 Million 1.23 Billion 846.62 Million 890.47 Million -1.01 Billion
Common Stock 197 Thousand 180 Thousand 178 Thousand 154 Thousand 142 Thousand 63 Thousand
Retained Earnings -5.36 Billion -4.43 Billion -3.55 Billion -2.77 Billion -2.09 Billion -615.81 Million
Accumulated other comprehensive income -504.46 Million -518.51 Million -550.94 Million -509.81 Million -467.5 Million -14.75 Million
Common Stock Equity 60.41 Million 408.65 Million 1.23 Billion 846.62 Million 890.47 Million -1.01 Billion
Capital Lease Obligation 22.68 Million 17.22 Million 17.89 Million 11.89 Million 16.4 Million 42.04 Million
Total Investments 18.94 Million 30.43 Million 31.98 Million 34.8 Million 34.79 Million 59.51 Million
Total Debt 1.79 Billion 1.79 Billion 1.08 Billion 529.69 Million 101.4 Million 42.04 Million
Net Debt 726.29 Million 300.48 Million -659.53 Million -494.7 Million -781.05 Million -915.04 Million

Balance Sheet Charts